| Literature DB >> 2154272 |
H Rollag1, S A Evensen, S S Frøland, A Glomstein.
Abstract
The prevalence of serological markers for present and past hepatitis B virus (HBV) infection and antibodies against cytomegalovirus (CMV) among Norwegians with coagulation factor defects was examined in serum samples collected before virus-inactivated coagulation concentrates came into use. Sera collected in 1985/86 from 324 of 377 (86%) registered persons with such defects were available. Three persons were chronic carriers of HBsAg. The prevalence of HBV antibodies was 28% compared with about 5% in the general population. The highest prevalence rate was found among patients with severe haemophilia A (44%) and in patients with haemophilia B (39%). The prevalence of anti-CMV antibodies was 75% which is similar to that found in the general Norwegian population.Entities:
Mesh：
Substances：
Year: 1990 PMID： 2154272 DOI： 10.1007/BF01720514
Source DB: PubMed Journal: Blut ISSN： 0006-5242